BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6813535)

  • 1. [Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
    Ito S; Hirono S
    Rinsho Ketsueki; 1982 May; 23(5):730-5. PubMed ID: 6813535
    [No Abstract]   [Full Text] [Related]  

  • 2. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 4. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An autopsy case of microangiopathic hemolytic anemia following the anti-cancer drug therapy--anticancer drugs and disseminated intravascular coagulation-- (author's transl)].
    Ohno Y; Kitamura K; Murata Y; Koya M; Furukawa H; Kanoh T; Uchino H
    Rinsho Ketsueki; 1980 Jun; 21(6):828-33. PubMed ID: 7463739
    [No Abstract]   [Full Text] [Related]  

  • 7. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
    Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
    Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
    Waldhorn RE; Tsou E; Smith FP; Kerwin DM
    Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible microangiopathic hemolytic anemia after mitomycin C.
    Perry DJ
    Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemolytic anemia associated with antineoplastic agents.
    Doll DC; Weiss RB
    Cancer Treat Rep; 1985; 69(7-8):777-82. PubMed ID: 3160460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rash, nephritis, hypertension, and haemolysis in patient on 5-fluorouracil, doxorubicin, and mitomycin-C.
    Karlin DA; Stroehlein JR
    Lancet; 1980 Sep; 2(8193):534-5. PubMed ID: 6105582
    [No Abstract]   [Full Text] [Related]  

  • 12. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy.
    Mach-Pascual S; Samii K; Beris P
    Am J Hematol; 1996 Aug; 52(4):310-2. PubMed ID: 8701950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin-C.
    Lempert KD
    Lancet; 1980 Aug; 2(8190):369-70. PubMed ID: 6105503
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
    Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
    Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil.
    Gulati SC; Sordillo P; Kempin S; Reich L; Magill GB; Scheiner E; Clarkson B
    Cancer; 1980 May; 45(9):2252-7. PubMed ID: 7379025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
    Dacie JV
    Recenti Prog Med; 1973 Jan; 54(1):1-22. PubMed ID: 4739645
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of dipyridamole and aspirin in thrombotic microangiopathy.
    Giromini M; Bouvier CA; Dami R; Denizot M; Jeannet M
    Br Med J; 1972 Feb; 1(5799):545-6. PubMed ID: 5062699
    [No Abstract]   [Full Text] [Related]  

  • 18. Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patients.
    Bruntsch U; Groos G; Tigges FJ; Gallmeier WM
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):905-9. PubMed ID: 6540191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Moschowitz's disease: efficacy of anti-platelet aggregation agents].
    Gorin NC; Fraitag B; Feldman A; Vallot T; Couturier JY; Najman A; Duhamel G
    Nouv Presse Med; 1977 Dec; 6(42):3959-61. PubMed ID: 202923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
    Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
    Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.